Records containing: Hypercholesteremia
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2025-12-30Early Statin-Ezetimibe Combination vs. Statin Monotherapy to Achieve LDL-C < 70 mg/dL in Recent Ischemic Stroke Patients With Evidence of Atherosclerosis: A Randomized Controlled Trial
-
CLINICAL_TRIALS study record update · 2022-08-03Pharmacokinetics, Pharmacodynamics, Safety and Tolerability Study Following A Single Subcutaneous Injection of SHR-1209 in Healthy Subjects
-
CLINICAL_TRIALS study record update · 2021-12-20The Effect of Remote Ischemic Conditioning in Patients With Hypercholesterolemia
-
CLINICAL_TRIALS study record update · 2020-07-28Pediatric Preventative Health Screenings - Obesity and Family-Centered
-
CLINICAL_TRIALS study record update · 2020-06-25A 12-Week, Phase 2 Randomized, Placebo-Controlled, Double-Blind Study to Assess the Efficacy, Safety and Tolerability of Gemcabene in Subjects With Hypercholesterolemia Not Adequately Controlled on High-Intensity or Moderate-Intensity Stable Statin Therapy
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-06-25A Phase 2 Open-Label, Dose-Finding Study to Assess the Efficacy, Safety, and Tolerability of Gemcabene in Patients With Homozygous Familial Hypercholesterolemia on Stable, Lipid Lowering Therapy (COBALT-1)
-
CLINICAL_TRIALS study record update · 2020-04-09A Study of the Effect of Oral, Multiple-Dose 300 mg and 900 mg Gemcabene (CI-1027) Administration on the Steady-State Pharmacokinetics of Atorvastatin 80 mg
-
CLINICAL_TRIALS study record update · 2017-02-16A Worldwide, Multicenter, Double-Blind, Randomized, Parallel, Study to Evaluate the Efficacy of MK0524 to Improve Tolerability of Extended Release Niacin
-
CLINICAL_TRIALS study record update · 2014-03-13Effectiveness of Phytosterol Supplementation on Select Indices of Cardiovascular Risk
-
CLINICAL_TRIALS study record update · 2013-11-25A Double-blinded, Placebo-controlled Randomized Trial Assessing the Extent to Which Consumption of Two Different Amounts of a Non-Pharmaceutical Food Supplement Can Improve Cardiovascular Health
-
CLINICAL_TRIALS study record update · 2012-02-22Pattern of Statins Use in Catalonia
-
CLINICAL_TRIALS study record update · 2011-11-17ClinicalTrials.gov study NCT00408382
-
CLINICAL_TRIALS study record update · 2011-08-30An Observational Study Into the Usage and Efficacy of Crestor 5mg as a Start Dosage in Achieving the LDL-C Target Level in Both Statin-naive and Treated Primary and Secondary Prevention Patients With a High Risk of a Cardiovascular Event.
-
CLINICAL_TRIALS study record update · 2011-07-15A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Long-term Treatment of Hypercholesterolaemic Subjects With Coronary Heart Disease as Measured by Intravascular Ultrasonography
-
CLINICAL_TRIALS study record update · 2011-05-16Study of the Effects of Limicol (a Food Supplement) on LDL-cholesterol in Moderate Hypercholesterolemia Subjects
-
CLINICAL_TRIALS study record update · 2010-11-19An Open-label, Randomised, Multi-centre, Phase IIIb, Parallel Group Study to Compare the Efficacy and Safety of Rosuvastatin and Atorvastatin in Subjects With Type IIa and IIb Hypercholesterolaemia
-
CLINICAL_TRIALS study record update · 2010-11-19A Randomized, Double-blind, Placebo-controlled, Multicenter Parallel Group Phase III Study Measuring Effects on Intima Media Thickness: an Evaluation Of Rosuvastatin 40 mg (METEOR)
-
CLINICAL_TRIALS study record update · 2009-04-09C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients